ELTP
OQB Elite Pharmaceuticals, Inc.$0.2450 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2450, and at the day’s high of $0.2490
- YTD change
- -50.03%
- vs 20-day SMA
- -0.98%
- vs 200-day SMA
- -31.44%
Price ranges
Price & Performance
-0.13 (-35.28%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 70.1% away from all-time highs of $0.8194
- ELTP is down 50% since the beginning of the year
- ELTP is down 59% over the past 12 months
- ELTP is down 1% over the past 1 month
- 0% of all ELTP investors are betting against ELTP
ELTP reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -59.1%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0004
- Last 5 days
- -3.92%
- vs 8-day SMA
- -2.90%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. It operates through the following segments: Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). The ANDA segment includes generic pharmaceuticals. The NDA segment is composed of branded pharmaceuticals. The company was founded on October 1, 1997 and is headquartered in Northvale, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
